High-Dose PEG-Intron Pharmacokinetic Study in Patients With Melanoma (Study P04831 AM2)
Clinical trial NCT00457418 · COMPLETED
Trial details
- NCT number
- NCT00457418
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-20
- Primary completion
- 2008-05-27
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.